# Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

> **NCT00269737** · PHASE3 · COMPLETED · sponsor: **Alza Corporation, DE, USA** · enrollment: 7 (—)

## Conditions studied

- Pain
- Cancer

## Interventions

- **DRUG:** Fentanyl Transdermal Therapeutic System (TTS)

## Key facts

- **NCT ID:** NCT00269737
- **Lead sponsor:** Alza Corporation, DE, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1986-05
- **Primary completion:** —
- **Final completion:** 1988-02
- **Target enrollment:** 7 (—)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00269737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00269737, "Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00269737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*